XML 158 R39.htm IDEA: XBRL DOCUMENT v3.24.3
Schedule of Cash and Marketable Securities by Significant Investment Category (Details) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Cash and Cash Equivalents [Line Items]    
Cost $ 37,089,000 $ 33,919,000
Unrealized Gain/(Loss) (18,195,000) (17,325,000)
Fair Value 18,894,000 16,594,000
Cash and Cash Equivalents 11,631,000 6,615,000
Marketable securities 7,263,000 9,979,000
Cash [Member]    
Cash and Cash Equivalents [Line Items]    
Cost 11,561,000 6,545,000
Unrealized Gain/(Loss)
Fair Value 11,561,000 6,545,000
Cash and Cash Equivalents 11,561,000 6,545,000
Marketable securities
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]    
Cash and Cash Equivalents [Line Items]    
Cost 70,000 70,000
Unrealized Gain/(Loss)
Fair Value 70,000 70,000
Cash and Cash Equivalents 70,000 70,000
Marketable securities
Marketable Securities [Member] | Fair Value, Inputs, Level 1 [Member]    
Cash and Cash Equivalents [Line Items]    
Cost 25,458,000 27,304,000
Unrealized Gain/(Loss) (18,195,000) (17,325,000)
Fair Value 7,263,000 9,979,000
Cash and Cash Equivalents
Marketable securities $ 7,263,000 $ 9,979,000